Using a State-Bounding Observer to Predict the Guaranteed Limits of Drug Amounts in Rats after Oral Administration...

Area of Science:

• Pharmacokinetics and Drug Delivery
• Systems Biology and Modeling
• Biomedical Engineering

Background:

• Uncertainty in pharmacokinetic models poses challenges for predicting drug concentrations.
• Ensuring drug concentrations remain within the therapeutic range is critical for patient safety and efficacy.
• Accurate monitoring of drug levels, especially in inaccessible body compartments, remains a significant challenge.

Purpose of the Study:

• To resolve the problem of using uncertain pharmacokinetic models for drug concentration determination.
• To design a generalized pharmacokinetic model that establishes guaranteed drug concentration limits.
• To develop a state-bounding observer for predicting drug concentration risks and therapeutic range adherence.

Main Methods:

• Development of a generalized pharmacokinetic model incorporating uncertainty.
• Design of a state-bounding observer driven by direct concentration measurements.
• Application of the observer to predict drug concentration limits in various body compartments.

Main Results:

• The generalized model successfully determines guaranteed limits for drug concentrations in rats.
• The state-bounding observer accurately predicts upper and lower concentration limits, including in inaccessible compartments.
• The observer effectively identifies potential risks of drug concentrations falling outside the therapeutic range.

Conclusions:

• The proposed pharmacokinetic modeling and state-bounding observer approach effectively manages uncertainty in drug concentration prediction.
• This method enhances the ability to maintain drug concentrations within therapeutic ranges, improving safety and efficacy.
• The developed observer is valuable for real-time drug concentration monitoring and risk assessment, particularly in complex physiological systems.